CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 266 enrolled
Drug / intervention
blood samples are taken onceprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00146705
NCT00146705N/ACompleted
CompareCT.gov

Long Term Follow-up of Pegylated-Interferon Alpha-2b and Lamivudine Combination Therapy in Patients With Chronic HBV Infection

Foundation for Liver Research·observational·Posted Sep 7, 2005·Updated Aug 1, 2007

In Brief

An observational study evaluating blood samples are taken once for Chronic Hepatitis B. Completed, enrolled 266 participants across 1 site.

Detailed Summary

The aim of this study was to investigate the long term outcome of Peginterferon alpha-2b with or without the addition of lamivudine in patients with chronic hepatitis B

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Hepatitis B
CountriesNetherlands
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 7, 2005
Enrollment StartMay 1, 2005
Study CompletionSep 1, 2006
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

blood samples are taken onceprocedure